|Bid||75.03 x 1000|
|Ask||0.00 x 1300|
|Day's range||75.52 - 76.59|
|52-week range||53.22 - 78.17|
|Beta (5Y monthly)||0.59|
|PE ratio (TTM)||N/A|
|Earnings date||27 Apr 2022 - 02 May 2022|
|Forward dividend & yield||2.16 (3.20%)|
|Ex-dividend date||06 Jan 2022|
|1y target est||72.50|
BridgeBio (BBIO) forms an exclusive partnership with Bristol Myers (BMY) to develop and commercialize its SHP2 inhibitor.
NEW YORK & SEOUL, May 13, 2022--LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...